Gabriel Cabot
Gabriel Cabot
Verified email at
Cited by
Cited by
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ...
Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study
G Cabot, AA Ocampo-Sosa, F Tubau, MD Macia, C Rodríguez, B Moya, ...
Antimicrobial agents and chemotherapy 55 (5), 1906-1911, 2011
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ...
Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
E Riera, G Cabot, X Mulet, M García-Castillo, R del Campo, C Juan, ...
Journal of antimicrobial chemotherapy 66 (9), 2022-2027, 2011
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates
G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016
Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections
C Peña, G Cabot, S Gómez-Zorrilla, L Zamorano, A Ocampo-Sosa, ...
Clinical Infectious Diseases 60 (4), 539-548, 2015
The Versatile Mutational Resistome of Pseudomonas aeruginosa
C López-Causapé, G Cabot, E del Barrio-Tofiño, A Oliver
Frontiers in microbiology 9, 685, 2018
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
PA Fraile-Ribot, G Cabot, X Mulet, L Periañez, ML Martín-Pena, C Juan, ...
Journal of Antimicrobial Chemotherapy 73 (3), 658-663, 2018
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain
E del Barrio-Tofiño, C López-Causapé, G Cabot, A Rivera, N Benito, ...
Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 01589-17, 2017
Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics
A Khaledi, A Weimann, M Schniederjans, E Asgari, TH Kuo, A Oliver, ...
EMBO molecular medicine 12 (3), e10264, 2020
Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone
C López-Causapé, LM Sommer, G Cabot, R Rubio, AA Ocampo-Sosa, ...
Scientific reports 7 (1), 5555, 2017
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones
X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ...
Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013
Alterations of OprD in carbapenem-intermediate and-susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study
AA Ocampo-Sosa, G Cabot, C Rodríguez, E Roman, F Tubau, MD Macia, ...
Antimicrobial agents and chemotherapy 56 (4), 1703-1713, 2012
Deciphering the resistome of the widespread Pseudomonas aeruginosa sequence type 175 international high-risk clone through whole-genome sequencing
G Cabot, C López-Causapé, AA Ocampo-Sosa, LM Sommer, ...
Antimicrobial agents and chemotherapy 60 (12), 7415-7423, 2016
Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology
E del Barrio-Tofiño, L Zamorano, S Cortes-Lara, C López-Causapé, ...
Journal of Antimicrobial Chemotherapy 74 (7), 1825-1835, 2019
Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals
M García-Castillo, R Del Campo, MI Morosini, E Riera, G Cabot, ...
Journal of clinical microbiology 49 (8), 2905-2910, 2011
Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection
C Lopez-Causape, E Rojo-Molinero, X Mulet, G Cabot, B Moya, ...
PLoS One 8 (8), e71001, 2013
Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure
A Ropy, G Cabot, I Sánchez-Diener, C Aguilera, B Moya, JA Ayala, ...
Antimicrobial agents and chemotherapy 59 (7), 3925-3934, 2015
In Vivo Emergence of Resistance to Novel Cephalosporin–β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β …
PA Fraile-Ribot, X Mulet, G Cabot, E del Barrio-Tofiño, C Juan, JL Pérez, ...
Antimicrobial agents and chemotherapy 61 (9), 10.1128/aac. 01117-17, 2017
The system can't perform the operation now. Try again later.
Articles 1–20